Compare AstraZeneca plc (AZN) vs GoPro Inc (GPRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs GoPro Inc — how do they compare? AstraZeneca plc trades at $158.11 (market cap $248.14B), while GoPro Inc trades at $0.62 (market cap $114.41M). The key difference: AstraZeneca plc is far larger — about 2168.9× GoPro Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while GoPro Inc pays none. Which is the better fit depends on your goals.
| AZN | GPRO | |
|---|---|---|
Market Cap | $248.14B | $114.41M |
Sector | Health | Technology |
52-Week High | $209.48 | $2.88 |
52-Week Low | $147.06 | $0.62 |
Enterprise Value | $275.41B | $173.19M |
Dividend Yield | 2.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →
